anmelden
SMI Equal Weight
372,28
PKT
-0,21
PKT
-0,06
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SMI Equal Weight-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 27.01.05 | Holcim Neutral | Helvea | |
| 03.02.05 | Novartis Outperformer | Sparkasse KölnBonn | |
| 27.01.05 | Holcim Halten | Helaba Trust | |
| 27.01.05 | Lonza Buy | Helvea | |
| 26.01.05 | Novartis Market Perform | William Blair | |
| 26.01.05 | Lonza Reduce | Sarasin Research | |
| 26.01.05 | UBS Buy | Sarasin Research | |
| 25.01.05 | Holcim Accumulate | Helvea | |
| 25.01.05 | Novartis Buy | Helvea | |
| 25.01.05 | Lonza Overweight | JP Morgan | |
| 25.01.05 | UBS Buy | Helvea | |
| 25.01.05 | Novartis Halten | LB Baden-Württemberg | |
| 25.01.05 | Swisscom Underweight | Lehman Brothers | |
| 25.01.05 | Novartis Outperform | Goldman Sachs | |
| 26.01.05 | Nestlé Outperform | Credit Suisse First Boston | |
| 24.01.05 | Novartis Overweight | Prudential Securities | |
| 24.01.05 | Holcim Neutral | Sarasin Research | |
| 25.01.05 | Novartis Neutral | Sarasin Research | |
| 24.01.05 | Richemont Outperform | Goldman Sachs | |
| 24.01.05 | Novartis Neutral | Sarasin Research | |
| 24.01.05 | Richemont Neutral | Merrill Lynch | |
| 24.01.05 | Lonza Reduce | Sarasin Research | |
| 21.01.05 | Zurich Insurance Buy | Sarasin Research | |
| 21.01.05 | Roche Buy | Sarasin Research | |
| 24.01.05 | Novartis Neutral | HypoVereinsbank | |
| 21.01.05 | Richemont Buy | Sarasin Research | |
| 21.01.05 | Zurich Insurance Accumulate | Helvea | |
| 21.01.05 | Novartis Kaufen | Helaba Trust | |
| 21.01.05 | Richemont Accumulate | Helvea | |
| 24.01.05 | Novartis Kaufen | Hamburger Sparkasse | |
| 21.01.05 | Richemont Buy | Sarasin Research | |
| 21.01.05 | Logitech Accumulate | Helvea | |
| 21.01.05 | Holcim Accumulate | Helvea | |
| 21.01.05 | ABB (Asea Brown Boveri) Neutral | Sarasin Research | |
| 24.01.05 | ABB (Asea Brown Boveri) Kaufen | NATIONAL-BANK | |
| 20.01.05 | Zurich Insurance Buy | Sarasin Research | |
| 20.01.05 | Novartis Hold | SEB | |
| 20.01.05 | Holcim Halten | Helaba Trust | |
| 20.01.05 | Novartis Akkumulieren | Independent Research | |
| 20.01.05 | Holcim Neutral | Sarasin Research |